Eko secures £16m in Series B funding to develop solutions for cardiac disease
Eko will use the funding to advance research and development and commercialisation of its machine learning platform for…
NS Healthcare is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X